000 01527 a2200433 4500
005 20250516194428.0
264 0 _c20141205
008 201412s 0 0 eng d
022 _a1757-4684
024 7 _a10.1002/emmm.201303214
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLarrayoz, Marta
245 0 0 _aContrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype.
_h[electronic resource]
260 _bEMBO molecular medicine
_c04 2014
300 _a539-50 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aPyrroles
_xadministration & dosage
650 0 4 _aSunitinib
650 0 4 _aTreatment Outcome
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aPio, Ruben
700 1 _aPajares, MarĂ­a J
700 1 _aZudaire, Isabel
700 1 _aAjona, Daniel
700 1 _aCasanovas, Oriol
700 1 _aMontuenga, Luis M
700 1 _aAgorreta, Jackeline
773 0 _tEMBO molecular medicine
_gvol. 6
_gno. 4
_gp. 539-50
856 4 0 _uhttps://doi.org/10.1002/emmm.201303214
_zAvailable from publisher's website
999 _c23520218
_d23520218